All In Biotech

Drug Trial Radar · NCT07773103

Endothelial Markers and Tadalafil Response

Endothelial Dysfunction Markers as Predictors of Clinical Response to Daily Tadalafil in Men With Vasculogenic Erectile Dysfunction

Last checked: Nov 20, 2026Latest source record: Aug 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

120

Planned (sponsor's estimate)

Start

Aug 19, 2026

Primary completion

Aug 2028

Study completion Dec 2028

Sponsor

Lead sponsor
Al-Azhar UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 19, 2026

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
No
Who can join
Male only, from 30 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This prospective cohort study will recruit eligible men attending the Urology/Andrology outpatient clinic. Baseline assessment will include demographic and clinical data, cardiovascular risk assessment, erectile-function questionnaires, routine laboratory investigations, brachial artery flow-mediated dilatation, carotid intima-media thickness, and selected circulating endothelial biomarkers including endothelin-1, nitrite/nitrate, high-sensitivity C-reactive protein, soluble vascular cell adhesion molecule-1, and soluble intercellular adhesion molecule-1. All participants will receive tadalafil 5 mg once daily for 12 weeks. Erectile function, adherence, and adverse events will be assessed during follow-up. The primary outcome will be clinical response at 12 weeks, defined as an improvement of at least 4 points in the IIEF-EF domain together with a positive response to the Global Assessment Question.

Conditions

  • Vasculogenic Erectile Dysfunction

Interventions

  • Tadalafil 5mgDrug

    All enrolled participants will receive tadalafil 5 mg orally once daily for 12 weeks as part of clinical management.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical response to tadalafil at 12 weeksTime frame: 12 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Department of Urology, Al-Hussein and Sayed Galal University Hospitals, Al-Azhar University

    Cairo, Egypt · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.